NCT01470118 - A Study to Evaluate the Duration of LASTACAFT® in Acute Allergic Conjunctivitis | Biotech Hunter

Enrollment

127

Participants

Timeline

Start Date

October 31, 2011

Primary Completion Date

December 31, 2011

Study Completion Date

December 31, 2011

Conditions

Conjunctivitis, Allergic

Interventions

DRUG

alcaftadine 0.25% ophthalmic solution

One drop of alcaftadine 0.25% ophthalmic solution instilled in each eye at Day 0 and Day 14.

DRUG

olopatadine 0.2% ophthalmic solution

One drop of olopatadine 0.2% ophthalmic solution instilled in each eye at Day 0 and Day 14.

DRUG

dextran 70 0.1%/hydroxypropyl methylcellulose 0.3%

One drop of placebo instilled in each eye at Day 0 and Day 14.

Trial Locations (1)

Philadelphia